II. Definitions
- Hypereosinophilic Syndrome
- Group of conditions with Eosinophils >1500 cells/uL >6 months with organ involvement and no cause found
III. Epidemiology
- Gender: Men are 10 fold more likely to be affected than women
- Age: 20 to 50 years old
IV. Symptoms
- Symptoms vary by specific Hypereosinophilic Syndrome
- Fever
- Cardiopulmonary
- Rheumatologic
- Myalgias
- Arthralgias
- Neurologic
- Vertigo
- Weakness
- Blurred Vision
- Skin
- Rash
- Pruritus
V. Imaging
-
Chest XRay
- Lung infiltrates seen in >30% of cases
- Pleural Effusions
VI. Labs
-
Complete Blood Count (CBC)
- Eosinophilia with >=1500 cells/uL (all cases, defining feature)
- Thrombocytopenia (>5% of cases)
- Anemia
VII. Diagnosis
- Absolute Eosinophil Count >=1500 cells/uL for 6 months or more AND
- No cause identified AND
- Organ involvement with Eosinophilic tissue infiltration
VIII. Differential Diagnosis
- See Eosinophilia
- Familial Hypereosinophilic Syndrome (rare)
- Myeloproliferative Hypereosinophilic Syndrome (e.g. myeloid Leukemia, See Eosinophilia)
-
Lymphocytic Hypereosinophilic Syndrome
- Increased Interkeukin-5 (Cytokine)
IX. Management
- First-Line Management
- Corticosteroids (e.g. Prednisone)
- Second-Line Management Options (Corticosteroid refractory Hypereosinophilia)
- Hydroxyurea
- Interferon-Alpha
- Imatinab (Gleevec)
- Third-Line Refractory Cases
- Cyclosporin
- Bone Marrow Transplant
- Other Specific Management
X. Complications
XI. Resources
- Hypereosinophilic Syndrome (NIH)
XII. References
- Mahmoudi (2014) Immunology Made Ridiculously Simple, MedMaster, Miami, FL